GRASP Training III
Join us for a training session so that you can be prepared for your upcoming event. Whether joining as a GRASP scientist, poster author, mentor, or patient advocate, these sessions will help you understand your respective role.
GRASP brings patients and researchers together for small-group conversations that make cancer science more accessible, collaborative, and deeply informed by patient experience.
Join us for a training session so that you can be prepared for your upcoming event. Whether joining as a GRASP scientist, poster author, mentor, or patient advocate, these sessions will help you understand your respective role.
The 2023 San Antonio Breast Cancer Symposium (SABCS) will be held on December 5-9, 2023. This year’s SABCS conference will be held as a hybrid conference with both in-person events and live web streaming. The Symposium aims to achieve a balance of clinical, translational, and basic research, providing a forum for interaction, communication, and education for a […]
Join Gitte Zels, a PhD student and Resident in Anatomic Pathology at KU Leuven, as she discusses her ILC23 poster titled “Overview of patients with invasive lobular breast carcinoma included in the post-mortem tissue donation program, UPTIDER.” The discussion will focus on the role of tumor heterogeneity in metastatic breast cancer, particularly in invasive lobular […]
GRASP / ASCL Reception for advocates and scientists Scientists: Meet the people whose lives are impacted by your work. Patient advocates: Meet the people who dedicate their careers to improving and extending your lives. Advancing the Science of Cancer in Latinos scientists whose posters are being discussed by GRASP and advocates are invited to attend […]
Join us for a special Huddle featuring Luminate Medical, a medical device company based in Ireland, focused on improving the quality of life for patients undergoing chemotherapy. Luminate Medical is seeking feedback from individuals who have experienced chemotherapy, past or present, to provide valuable insights on their innovative product designs aimed at addressing hair loss […]
Join us for a special Huddle featuring Luminate Medical, a medical device company based in Ireland, focused on improving the quality of life for patients undergoing chemotherapy. Luminate Medical is seeking feedback from individuals who have experienced chemotherapy, past or present, to provide valuable insights on their innovative product designs aimed at addressing hair loss […]
Join Dr. Rachel Dittmar, Ph.D., as she discusses the Final Gift Program, a tissue donation initiative at MD Anderson Cancer Center. This program enables patients with metastatic breast cancer to make a profound impact on research by donating tissue after their passing, allowing scientists to better understand the disease at its most advanced stages. Learn […]
GRASP will be held in conjunction with the 2025 American Society of Clinical Oncology (ASCO) annual meeting which is attended by more than 40,000 oncology professionals from around the world to discuss the latest advancements in cancer care treatments. GRASP sessions will be held after the conference on June 12-13, 2024. GRASP brings scientists and patient advocates together […]
Dr. Marielle Gross will discuss Decentralized Biobanking, AKA “de-bi,” a new community engagement platform for patients to track their donated biosamples, receive personalized research updates, and engage with scientists in a privacy-preserving network. We will share details about our first de-bi pilot, launched in 2023 for a large breast cancer biobank. Next, we will take […]
Dr. Shoshana Rosenberg will review poster “Effects of plant-based diet (PBD) and exercise therapy (Ex) on weight and body composition in patients with primary hormone receptor (HR) positive breast cancer: A phase 2 randomized controlled trial.” This study explores how a personalized energy-restricted PBD combined with exercise can impact weight and body composition in patients […]
Elisabeth de Kermadec will discuss the OPERA-01 phase 3 study, focusing on the efficacy of palazestrant (OP-1250) compared to standard treatments in ER+, HER2- metastatic breast cancer post endocrine therapy and CDK4/6 inhibitor resistance. We will discuss her study and review the poster “the OPERA-01 phase 3 study with us, focusing on the efficacy of […]
Dr. Gaia Griguolo will discuss her research and review the poster “Association of tumor-infiltrating lymphocytes (TILs) and immune signatures with PAM50 intrinsic subtyping hormone receptor-positive (HR+)/HER2-negative (HER2-) early breast cancer (BC): A translational analysis of two multicentric neoadjuvant trial” which was presented at the 2024 American Society of Clinical Oncology Annual Meeting (ASCO). This session […]

GUIDING RESEARCHERS & ADVOCATES TO SCIENTIFIC PARTNERSHIPS
